Akari Therapeutics (NasdaqCM:AKTX) Update / briefing Transcript

Akari Therapeutics (NasdaqCM:AKTX) Update / briefing February 10, 2026 07:00 PM ET Company ParticipantsAbizer Gaslightwala - CEOJenene Thomas - CEOAbizer GaslightwalaWe've always said we believe our payload can be attached to many different types of antigen targets and molecules and create a library or pipeline of ADC molecules. And so this is the power of the payload coming to fruition.Jenene ThomasWelcome back, and thank you for joining us for another Virtual Investor: What This Means segment. My name is ...